HF Best Ideas
AnalysesQuarterly LettersWarren AI
All funds

Bronte Capital

Jun 2025 → Jul 2026 · Publishes quarterly · 2 funds

Our archive holds 7 letters from Bronte Capital, behind 6 investment theses and positions in 10 companies. Every quote below is copied verbatim from the letter it came from.

Writes about

Get an email when this fund publishes its next letter

Bronte Capital’s own letters page
7
Letters
10
Companies
1
Moves
6
Theses

What they bought and sold · 1 move

  • TrimmedGoogle
    July 2026
    “We keep trimming the stock. And we know in the end we will be squeamish about the outcome.”
    Read the letter

Companies held · 10

Every company Bronte Capital has disclosed a position in across our archive, with the letter that last mentioned it.

Theses · 6

  • Alphabet
    July 2026

    Alphabet is seen as a highly capable company pivoting aggressively into AI, but with an existential threat to its search business.

    Read the full thesis
  • Alphabet
    June 2026

    Alphabet is held despite search disruption because management is highly capable, the company is aggressively pivoting into AI, and the investment case hinges on whether it can replace its legacy ad business with superintelligence-driven returns.

    Read the full thesis
  • Coca-Cola
    March 2026

    Coca-Cola is a stunning consumer staples business with high returns on capital, strong cash generation, and powerful brand and distribution advantages.

    Read the full thesis
  • Regeneron Pharmaceuticals Inc.
    November 2025

    Regeneron leverages proprietary genetic and mouse-model platforms to de-risk and accelerate drug discovery, offering substantial long-term upside from its current below-market valuation.

    Read the full thesis
  • DSM-Firmenich
    September 2025

    DSM-Firmenich is undervalued at 1.6x EV/sales with structurally high-margin perfumery and fragrance segments, strong management and minimal debt.

    Read the full thesis
  • Holcim
    June 2025

    Holcim is an attractive investment now due to its improved profitability in Europe and the strong potential of its newly spun-off American division, Amrize.

    Read the full thesis

Letter archive · 7

2026

2025

Get Bronte Capital’s next letter the day it lands

We track Bronte Capital alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.

View plans→
Share this fund